| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Editing | 29 | 2025 | 301 | 6.350 |
Why?
|
| CRISPR-Cas Systems | 26 | 2025 | 332 | 3.800 |
Why?
|
| Zebrafish | 18 | 2023 | 323 | 3.350 |
Why?
|
| Zinc Fingers | 15 | 2015 | 96 | 3.260 |
Why?
|
| Gene Targeting | 9 | 2020 | 80 | 1.930 |
Why?
|
| Endonucleases | 8 | 2022 | 81 | 1.780 |
Why?
|
| DNA | 21 | 2023 | 802 | 1.730 |
Why?
|
| Nerve Transfer | 3 | 2015 | 6 | 1.490 |
Why?
|
| Brachial Plexus | 3 | 2015 | 6 | 1.480 |
Why?
|
| Base Sequence | 19 | 2022 | 1301 | 1.470 |
Why?
|
| Transcription Factors | 19 | 2022 | 1482 | 1.420 |
Why?
|
| Hematopoietic Stem Cells | 10 | 2024 | 275 | 1.340 |
Why?
|
| Two-Hybrid System Techniques | 8 | 2011 | 66 | 1.330 |
Why?
|
| Deoxyribonucleases | 5 | 2017 | 30 | 1.290 |
Why?
|
| Genome | 5 | 2023 | 256 | 1.240 |
Why?
|
| CRISPR-Associated Proteins | 3 | 2019 | 31 | 1.220 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 5 | 2019 | 92 | 1.220 |
Why?
|
| Binding Sites | 18 | 2023 | 893 | 1.200 |
Why?
|
| Animals | 69 | 2025 | 19739 | 1.180 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 3 | 2013 | 25 | 1.150 |
Why?
|
| Zebrafish Proteins | 9 | 2019 | 150 | 1.150 |
Why?
|
| Protein Engineering | 7 | 2019 | 77 | 1.130 |
Why?
|
| Ribonucleoproteins | 4 | 2025 | 112 | 1.060 |
Why?
|
| Homeodomain Proteins | 6 | 2019 | 257 | 1.040 |
Why?
|
| Drosophila Proteins | 6 | 2013 | 682 | 1.010 |
Why?
|
| DNA Breaks, Double-Stranded | 4 | 2023 | 77 | 0.990 |
Why?
|
| RNA-Directed DNA Polymerase | 2 | 2024 | 34 | 0.970 |
Why?
|
| Peripheral Nerves | 2 | 2015 | 30 | 0.960 |
Why?
|
| Microsurgery | 2 | 2015 | 52 | 0.940 |
Why?
|
| Deoxyribonucleotides | 1 | 2024 | 13 | 0.930 |
Why?
|
| Radial Nerve | 1 | 2024 | 2 | 0.930 |
Why?
|
| Nerve Compression Syndromes | 1 | 2024 | 11 | 0.920 |
Why?
|
| DNA-Binding Proteins | 9 | 2015 | 1142 | 0.900 |
Why?
|
| Regulatory Elements, Transcriptional | 5 | 2015 | 37 | 0.860 |
Why?
|
| Fetal Hemoglobin | 6 | 2024 | 12 | 0.860 |
Why?
|
| Terminology as Topic | 1 | 2024 | 138 | 0.850 |
Why?
|
| Repressor Proteins | 8 | 2024 | 337 | 0.850 |
Why?
|
| Cold Temperature | 1 | 2023 | 51 | 0.840 |
Why?
|
| HEK293 Cells | 9 | 2025 | 585 | 0.780 |
Why?
|
| DNA, Single-Stranded | 1 | 2022 | 100 | 0.750 |
Why?
|
| Sequence Analysis, DNA | 5 | 2018 | 396 | 0.730 |
Why?
|
| Software | 7 | 2023 | 376 | 0.720 |
Why?
|
| Databases, Genetic | 3 | 2017 | 85 | 0.720 |
Why?
|
| Mice | 34 | 2025 | 10317 | 0.710 |
Why?
|
| Chromosome Inversion | 3 | 2024 | 18 | 0.700 |
Why?
|
| DNA End-Joining Repair | 2 | 2019 | 24 | 0.660 |
Why?
|
| Sequence Deletion | 2 | 2019 | 114 | 0.650 |
Why?
|
| Connectin | 1 | 2019 | 10 | 0.640 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2019 | 7 | 0.640 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2019 | 10 | 0.640 |
Why?
|
| Humans | 56 | 2025 | 60081 | 0.630 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2018 | 6 | 0.630 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 6 | 2024 | 329 | 0.620 |
Why?
|
| Nucleotide Motifs | 4 | 2018 | 50 | 0.610 |
Why?
|
| Drosophila melanogaster | 5 | 2015 | 481 | 0.590 |
Why?
|
| Drosophila | 5 | 2013 | 420 | 0.580 |
Why?
|
| Animals, Genetically Modified | 6 | 2022 | 281 | 0.570 |
Why?
|
| INDEL Mutation | 3 | 2022 | 18 | 0.540 |
Why?
|
| Statistics as Topic | 1 | 2017 | 146 | 0.540 |
Why?
|
| Bacterial Proteins | 4 | 2019 | 734 | 0.530 |
Why?
|
| K562 Cells | 3 | 2022 | 58 | 0.520 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2015 | 3 | 0.510 |
Why?
|
| Elbow Joint | 1 | 2015 | 13 | 0.510 |
Why?
|
| Shoulder Joint | 1 | 2015 | 23 | 0.510 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 2015 | 3 | 0.480 |
Why?
|
| Giant Cell Tumors | 1 | 2015 | 5 | 0.480 |
Why?
|
| Body Patterning | 4 | 2011 | 85 | 0.470 |
Why?
|
| Mutagenesis | 4 | 2021 | 131 | 0.470 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 1542 | 0.460 |
Why?
|
| Genetic Engineering | 3 | 2018 | 111 | 0.450 |
Why?
|
| Protein Binding | 12 | 2021 | 1571 | 0.440 |
Why?
|
| Genome, Human | 4 | 2021 | 221 | 0.440 |
Why?
|
| Mammals | 3 | 2023 | 207 | 0.430 |
Why?
|
| Bacteria | 6 | 2011 | 277 | 0.420 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 41 | 0.420 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 302 | 0.410 |
Why?
|
| gamma-Globins | 3 | 2020 | 4 | 0.380 |
Why?
|
| Mutation | 9 | 2024 | 2466 | 0.380 |
Why?
|
| Developmental Biology | 1 | 2011 | 6 | 0.380 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2024 | 101 | 0.380 |
Why?
|
| Genetic Techniques | 1 | 2011 | 38 | 0.370 |
Why?
|
| Signal Transduction | 6 | 2024 | 2892 | 0.360 |
Why?
|
| Anemia, Sickle Cell | 5 | 2025 | 62 | 0.360 |
Why?
|
| Alleles | 6 | 2023 | 417 | 0.360 |
Why?
|
| Jurkat Cells | 3 | 2019 | 102 | 0.350 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 2 | 2021 | 17 | 0.350 |
Why?
|
| Range of Motion, Articular | 3 | 2015 | 87 | 0.340 |
Why?
|
| Computational Biology | 5 | 2013 | 337 | 0.340 |
Why?
|
| Molecular Sequence Data | 9 | 2014 | 1965 | 0.330 |
Why?
|
| Tyrosinemias | 2 | 2021 | 19 | 0.320 |
Why?
|
| Escherichia coli | 3 | 2014 | 688 | 0.310 |
Why?
|
| Tendons | 1 | 2008 | 23 | 0.310 |
Why?
|
| Cell Line | 4 | 2023 | 2008 | 0.310 |
Why?
|
| Embryonic Development | 4 | 2013 | 136 | 0.310 |
Why?
|
| Tendon Injuries | 1 | 2008 | 17 | 0.300 |
Why?
|
| Cell Proliferation | 3 | 2024 | 944 | 0.300 |
Why?
|
| Orthopedic Procedures | 1 | 2008 | 44 | 0.300 |
Why?
|
| Neisseria meningitidis | 2 | 2018 | 81 | 0.300 |
Why?
|
| Neurofibromatosis 1 | 2 | 2022 | 28 | 0.300 |
Why?
|
| Knee Injuries | 1 | 2008 | 49 | 0.290 |
Why?
|
| Gene Regulatory Networks | 3 | 2015 | 142 | 0.290 |
Why?
|
| Transfection | 3 | 2021 | 673 | 0.290 |
Why?
|
| Chromatin | 4 | 2023 | 602 | 0.290 |
Why?
|
| Amino Acid Sequence | 9 | 2019 | 1572 | 0.270 |
Why?
|
| Embryo, Nonmammalian | 5 | 2019 | 169 | 0.260 |
Why?
|
| Orotidine-5'-Phosphate Decarboxylase | 1 | 2006 | 1 | 0.260 |
Why?
|
| Genetic Markers | 1 | 2006 | 117 | 0.250 |
Why?
|
| Sequence Analysis | 1 | 2005 | 11 | 0.250 |
Why?
|
| Selection, Genetic | 1 | 2006 | 70 | 0.250 |
Why?
|
| Gene Silencing | 1 | 2008 | 379 | 0.250 |
Why?
|
| Amino Acid Motifs | 2 | 2012 | 153 | 0.250 |
Why?
|
| beta-Thalassemia | 3 | 2020 | 13 | 0.240 |
Why?
|
| Protein Interaction Mapping | 1 | 2005 | 71 | 0.240 |
Why?
|
| Leukocyte Common Antigens | 1 | 2024 | 57 | 0.240 |
Why?
|
| Cytosine | 1 | 2025 | 31 | 0.240 |
Why?
|
| Neuropilin-1 | 1 | 2024 | 12 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2024 | 26 | 0.240 |
Why?
|
| Moloney murine leukemia virus | 1 | 2024 | 17 | 0.240 |
Why?
|
| Radial Neuropathy | 1 | 2024 | 3 | 0.230 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2024 | 170 | 0.230 |
Why?
|
| Immunoconjugates | 1 | 2024 | 84 | 0.230 |
Why?
|
| Proprotein Convertase 9 | 2 | 2022 | 12 | 0.230 |
Why?
|
| Neurofibromin 1 | 2 | 2022 | 11 | 0.230 |
Why?
|
| Thermogenesis | 2 | 2023 | 108 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2013 | 496 | 0.220 |
Why?
|
| Blood Platelet Disorders | 1 | 2023 | 4 | 0.220 |
Why?
|
| DNA, Bacterial | 1 | 2005 | 257 | 0.220 |
Why?
|
| Transcriptional Activation | 2 | 2015 | 189 | 0.220 |
Why?
|
| Cold-Shock Response | 1 | 2023 | 3 | 0.220 |
Why?
|
| Genomics | 4 | 2018 | 317 | 0.220 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2019 | 630 | 0.220 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 1387 | 0.210 |
Why?
|
| Integrases | 1 | 2023 | 36 | 0.210 |
Why?
|
| Plasmids | 2 | 2019 | 283 | 0.210 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 45 | 0.210 |
Why?
|
| Erythroid Cells | 2 | 2021 | 9 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2024 | 201 | 0.210 |
Why?
|
| Genetic Vectors | 4 | 2021 | 818 | 0.210 |
Why?
|
| Penicillins | 5 | 1999 | 28 | 0.210 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2024 | 56 | 0.200 |
Why?
|
| Nucleic Acid Conformation | 3 | 2019 | 234 | 0.200 |
Why?
|
| Genes, Reporter | 4 | 2022 | 244 | 0.200 |
Why?
|
| ATP-Dependent Proteases | 1 | 2022 | 7 | 0.200 |
Why?
|
| Oxidative Phosphorylation | 1 | 2022 | 35 | 0.190 |
Why?
|
| Protein Structure, Tertiary | 3 | 2010 | 666 | 0.190 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2021 | 27 | 0.190 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 11 | 0.190 |
Why?
|
| Substrate Specificity | 3 | 2014 | 325 | 0.190 |
Why?
|
| Recombinational DNA Repair | 1 | 2021 | 20 | 0.190 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 78 | 0.190 |
Why?
|
| Adipocytes, Brown | 1 | 2021 | 45 | 0.190 |
Why?
|
| HeLa Cells | 2 | 2021 | 530 | 0.190 |
Why?
|
| Mitochondrial Proteins | 1 | 2022 | 99 | 0.180 |
Why?
|
| Carrier Proteins | 3 | 2025 | 703 | 0.180 |
Why?
|
| Leukocyte Elastase | 1 | 2021 | 12 | 0.180 |
Why?
|
| Adipocytes | 1 | 2023 | 253 | 0.180 |
Why?
|
| Gene Transfer Techniques | 3 | 2019 | 307 | 0.180 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2095 | 0.180 |
Why?
|
| Cells | 1 | 2021 | 31 | 0.180 |
Why?
|
| Recovery of Function | 2 | 2015 | 268 | 0.180 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 88 | 0.180 |
Why?
|
| Algorithms | 3 | 2023 | 1006 | 0.180 |
Why?
|
| Neutropenia | 1 | 2021 | 66 | 0.180 |
Why?
|
| Liver | 3 | 2022 | 785 | 0.180 |
Why?
|
| Models, Molecular | 3 | 2013 | 1139 | 0.180 |
Why?
|
| Dyskeratosis Congenita | 1 | 2020 | 3 | 0.170 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 113 | 0.170 |
Why?
|
| Nervous System Diseases | 1 | 2021 | 104 | 0.170 |
Why?
|
| Telomerase | 1 | 2020 | 30 | 0.170 |
Why?
|
| Huntington Disease | 1 | 2022 | 146 | 0.170 |
Why?
|
| Nuclear Proteins | 4 | 2019 | 760 | 0.170 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2012 | 257 | 0.170 |
Why?
|
| Carcinogenesis | 1 | 2021 | 119 | 0.170 |
Why?
|
| DNA Replication | 1 | 2022 | 231 | 0.170 |
Why?
|
| Chemokines | 2 | 2011 | 94 | 0.170 |
Why?
|
| Phylogeny | 2 | 2013 | 334 | 0.170 |
Why?
|
| Streptomyces | 6 | 1999 | 19 | 0.160 |
Why?
|
| Cell Differentiation | 6 | 2021 | 1298 | 0.160 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2019 | 15 | 0.160 |
Why?
|
| Nuclear Localization Signals | 1 | 2019 | 18 | 0.160 |
Why?
|
| Genetic Therapy | 3 | 2021 | 742 | 0.160 |
Why?
|
| Inverted Repeat Sequences | 1 | 2019 | 14 | 0.160 |
Why?
|
| beta-Globins | 1 | 2019 | 9 | 0.160 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 29 | 0.160 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2019 | 17 | 0.160 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 19 | 0.160 |
Why?
|
| Models, Biological | 6 | 2019 | 1142 | 0.160 |
Why?
|
| Lymphatic Vessels | 1 | 2019 | 31 | 0.160 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 22 | 0.160 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 75 | 0.160 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2018 | 14 | 0.160 |
Why?
|
| Mitochondria | 1 | 2022 | 338 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 137 | 0.150 |
Why?
|
| Gene Library | 3 | 2011 | 99 | 0.150 |
Why?
|
| Genes, Neurofibromatosis 1 | 2 | 2022 | 9 | 0.150 |
Why?
|
| Proteins | 1 | 2004 | 738 | 0.150 |
Why?
|
| Dependovirus | 2 | 2021 | 659 | 0.150 |
Why?
|
| Myoblasts | 1 | 2019 | 63 | 0.150 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2018 | 25 | 0.150 |
Why?
|
| Chromosome Mapping | 2 | 2018 | 283 | 0.150 |
Why?
|
| Heterochromatin | 1 | 2018 | 84 | 0.150 |
Why?
|
| Carpal Bones | 1 | 1997 | 3 | 0.150 |
Why?
|
| Wrist Joint | 1 | 1997 | 8 | 0.150 |
Why?
|
| HIV-1 | 1 | 2023 | 710 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 100 | 0.140 |
Why?
|
| RNA Splicing | 1 | 2019 | 160 | 0.140 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 161 | 0.140 |
Why?
|
| Obesity | 2 | 2023 | 1191 | 0.140 |
Why?
|
| Nucleotides | 2 | 2018 | 41 | 0.140 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2022 | 402 | 0.140 |
Why?
|
| Heterografts | 3 | 2024 | 62 | 0.140 |
Why?
|
| Gene Order | 2 | 2016 | 29 | 0.140 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 59 | 0.140 |
Why?
|
| Transcription Activator-Like Effector Nucleases | 1 | 2016 | 4 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 184 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 154 | 0.130 |
Why?
|
| Proteomics | 1 | 2018 | 264 | 0.130 |
Why?
|
| Sensitivity and Specificity | 3 | 2006 | 1100 | 0.130 |
Why?
|
| HIV Infections | 1 | 2023 | 927 | 0.130 |
Why?
|
| Transformation, Bacterial | 2 | 2006 | 12 | 0.130 |
Why?
|
| RNA Editing | 1 | 2016 | 21 | 0.130 |
Why?
|
| Muscle Strength | 1 | 2015 | 37 | 0.130 |
Why?
|
| DNA Cleavage | 1 | 2015 | 18 | 0.130 |
Why?
|
| Electromyography | 1 | 2015 | 87 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 1481 | 0.120 |
Why?
|
| Adult | 5 | 2021 | 15972 | 0.120 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 296 | 0.120 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 2074 | 0.120 |
Why?
|
| Cephalosporins | 5 | 1999 | 16 | 0.120 |
Why?
|
| Sequence Alignment | 2 | 2013 | 291 | 0.120 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 628 | 0.120 |
Why?
|
| Insect Proteins | 2 | 2012 | 79 | 0.120 |
Why?
|
| Finger Joint | 1 | 2015 | 9 | 0.120 |
Why?
|
| Arm | 1 | 2014 | 38 | 0.120 |
Why?
|
| Morpholinos | 1 | 2014 | 50 | 0.120 |
Why?
|
| Rare Diseases | 1 | 2015 | 38 | 0.120 |
Why?
|
| Ankle Joint | 1 | 2015 | 43 | 0.120 |
Why?
|
| Treatment Outcome | 2 | 2015 | 5266 | 0.120 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 53 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 129 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 193 | 0.110 |
Why?
|
| Suture Techniques | 1 | 2014 | 86 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 248 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 661 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 2 | 2011 | 102 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 534 | 0.110 |
Why?
|
| Germ-Line Mutation | 3 | 2023 | 46 | 0.110 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 460 | 0.110 |
Why?
|
| Disability Evaluation | 1 | 2014 | 217 | 0.110 |
Why?
|
| Erythropoiesis | 3 | 2021 | 35 | 0.110 |
Why?
|
| Neoplasms | 2 | 2021 | 1262 | 0.110 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2014 | 133 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2014 | 67 | 0.110 |
Why?
|
| Chromosome Breakpoints | 1 | 2013 | 5 | 0.110 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2013 | 7 | 0.110 |
Why?
|
| DNA Primers | 1 | 2014 | 290 | 0.110 |
Why?
|
| Artificial Intelligence | 2 | 2014 | 173 | 0.110 |
Why?
|
| Recurrence | 1 | 2015 | 600 | 0.100 |
Why?
|
| Radiography | 1 | 2015 | 514 | 0.100 |
Why?
|
| Apoptosis | 1 | 2018 | 1042 | 0.100 |
Why?
|
| Stem Cells | 2 | 2012 | 258 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 852 | 0.100 |
Why?
|
| Oxidoreductases | 4 | 1988 | 65 | 0.100 |
Why?
|
| Response Elements | 1 | 2012 | 43 | 0.100 |
Why?
|
| Antigens, CD34 | 2 | 2024 | 53 | 0.100 |
Why?
|
| Germ Cells | 1 | 2013 | 97 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2013 | 252 | 0.100 |
Why?
|
| Butterflies | 1 | 2012 | 32 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 2013 | 121 | 0.100 |
Why?
|
| Endodeoxyribonucleases | 1 | 2012 | 40 | 0.100 |
Why?
|
| Macaca mulatta | 2 | 2024 | 246 | 0.100 |
Why?
|
| GATA2 Transcription Factor | 1 | 2011 | 8 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2012 | 110 | 0.100 |
Why?
|
| Molecular Docking Simulation | 1 | 2012 | 83 | 0.090 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 15 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 419 | 0.090 |
Why?
|
| Catalytic Domain | 1 | 2012 | 193 | 0.090 |
Why?
|
| Penicillin-Binding Proteins | 4 | 1998 | 9 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 196 | 0.090 |
Why?
|
| Cell Biology | 1 | 2011 | 21 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 74 | 0.090 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2023 | 83 | 0.090 |
Why?
|
| Veins | 1 | 2011 | 61 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 232 | 0.090 |
Why?
|
| Arteries | 1 | 2011 | 75 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2011 | 104 | 0.090 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2010 | 13 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2011 | 194 | 0.090 |
Why?
|
| Protein Conformation | 1 | 2013 | 774 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2011 | 236 | 0.080 |
Why?
|
| Oligopeptides | 3 | 1989 | 129 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2015 | 2480 | 0.080 |
Why?
|
| Oligonucleotides | 2 | 2024 | 210 | 0.080 |
Why?
|
| Enzymes | 4 | 1988 | 33 | 0.080 |
Why?
|
| Penicillin G | 2 | 1999 | 5 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2360 | 0.080 |
Why?
|
| Genes, Bacterial | 2 | 2006 | 114 | 0.080 |
Why?
|
| Male | 5 | 2021 | 27951 | 0.080 |
Why?
|
| Female | 6 | 2021 | 31226 | 0.080 |
Why?
|
| Aorta | 1 | 2009 | 106 | 0.080 |
Why?
|
| RNA | 2 | 2024 | 404 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2023 | 1995 | 0.080 |
Why?
|
| Genome, Insect | 1 | 2008 | 31 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2008 | 236 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2014 | 1175 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2015 | 1936 | 0.070 |
Why?
|
| Point Mutation | 2 | 2019 | 161 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2008 | 170 | 0.070 |
Why?
|
| Quality of Life | 1 | 2014 | 1140 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 679 | 0.070 |
Why?
|
| Insulin | 1 | 2011 | 692 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 2 | 2019 | 354 | 0.070 |
Why?
|
| Orotic Acid | 1 | 2006 | 1 | 0.070 |
Why?
|
| Larva | 2 | 2019 | 128 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 1224 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 5200 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 88 | 0.060 |
Why?
|
| Young Adult | 1 | 2015 | 4398 | 0.060 |
Why?
|
| Intramolecular Transferases | 4 | 1998 | 4 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2023 | 461 | 0.060 |
Why?
|
| Genes, Regulator | 1 | 2005 | 28 | 0.060 |
Why?
|
| Acremonium | 5 | 1988 | 5 | 0.060 |
Why?
|
| Morphogenesis | 2 | 2019 | 113 | 0.060 |
Why?
|
| Busulfan | 1 | 2024 | 11 | 0.060 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2024 | 4 | 0.060 |
Why?
|
| Adolescent | 1 | 2015 | 5944 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 236 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 3215 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2006 | 296 | 0.060 |
Why?
|
| Transplantation Conditioning | 1 | 2024 | 94 | 0.060 |
Why?
|
| Electroporation | 1 | 2024 | 32 | 0.060 |
Why?
|
| Leucine Zippers | 1 | 2003 | 12 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2010 | 617 | 0.060 |
Why?
|
| Peptide Library | 1 | 2003 | 36 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2004 | 356 | 0.050 |
Why?
|
| Dimerization | 1 | 2003 | 146 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 284 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2023 | 79 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2023 | 157 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2023 | 88 | 0.050 |
Why?
|
| Neurons | 2 | 2022 | 861 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2023 | 164 | 0.050 |
Why?
|
| Gene Expression | 1 | 2006 | 808 | 0.050 |
Why?
|
| Brain | 1 | 2011 | 1485 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 424 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2023 | 192 | 0.050 |
Why?
|
| Codon | 1 | 2022 | 49 | 0.050 |
Why?
|
| DNA Polymerase gamma | 1 | 2022 | 4 | 0.050 |
Why?
|
| Codon, Nonsense | 1 | 2022 | 51 | 0.050 |
Why?
|
| Ribonuclease H | 1 | 2022 | 18 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 558 | 0.050 |
Why?
|
| Biotinylation | 1 | 2022 | 38 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 215 | 0.050 |
Why?
|
| Biotin | 1 | 2022 | 52 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 845 | 0.050 |
Why?
|
| Histones | 2 | 2018 | 465 | 0.050 |
Why?
|
| Adipocytes, White | 1 | 2021 | 27 | 0.050 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 28 | 0.050 |
Why?
|
| Subcutaneous Fat | 1 | 2021 | 47 | 0.050 |
Why?
|
| Huntingtin Protein | 1 | 2022 | 138 | 0.050 |
Why?
|
| Peptide Synthases | 2 | 1992 | 3 | 0.050 |
Why?
|
| Proteolysis | 1 | 2022 | 137 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2021 | 96 | 0.040 |
Why?
|
| Nanoparticles | 2 | 2017 | 495 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 125 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 159 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 179 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2020 | 120 | 0.040 |
Why?
|
| Virulence | 1 | 2021 | 187 | 0.040 |
Why?
|
| Receptors, CXCR4 | 2 | 2011 | 32 | 0.040 |
Why?
|
| Goals | 1 | 2021 | 91 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 75 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 203 | 0.040 |
Why?
|
| Telomere | 1 | 2020 | 48 | 0.040 |
Why?
|
| Hemoglobinopathies | 1 | 2019 | 5 | 0.040 |
Why?
|
| Aged | 1 | 2015 | 13596 | 0.040 |
Why?
|
| Alcohols | 1 | 1999 | 13 | 0.040 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2019 | 8 | 0.040 |
Why?
|
| Face | 1 | 2019 | 34 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2019 | 185 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2022 | 457 | 0.040 |
Why?
|
| Cytokines | 1 | 2023 | 911 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 639 | 0.040 |
Why?
|
| APOBEC Deaminases | 1 | 2019 | 10 | 0.040 |
Why?
|
| Adenosine Deaminase | 1 | 2019 | 16 | 0.040 |
Why?
|
| Erythroid Precursor Cells | 1 | 2019 | 20 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 83 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2019 | 130 | 0.040 |
Why?
|
| Middle Aged | 1 | 2015 | 16542 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 516 | 0.040 |
Why?
|
| Azepines | 1 | 2018 | 19 | 0.040 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2018 | 31 | 0.040 |
Why?
|
| Multifunctional Enzymes | 1 | 2018 | 17 | 0.040 |
Why?
|
| Triazoles | 1 | 2018 | 52 | 0.040 |
Why?
|
| Artifacts | 1 | 2019 | 126 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1465 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 531 | 0.040 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2018 | 125 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 2018 | 59 | 0.040 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2017 | 32 | 0.040 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2017 | 5 | 0.040 |
Why?
|
| Joint Dislocations | 1 | 1997 | 16 | 0.040 |
Why?
|
| Cell Separation | 1 | 2018 | 146 | 0.040 |
Why?
|
| Wrist Injuries | 1 | 1997 | 15 | 0.040 |
Why?
|
| Critical Care | 1 | 2021 | 418 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 1997 | 62 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 273 | 0.040 |
Why?
|
| Leukemia | 1 | 2017 | 54 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2023 | 766 | 0.040 |
Why?
|
| Oncogenes | 1 | 2017 | 68 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 391 | 0.030 |
Why?
|
| Proteome | 1 | 2018 | 142 | 0.030 |
Why?
|
| beta Catenin | 1 | 2017 | 85 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 1997 | 75 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2017 | 91 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 1111 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 842 | 0.030 |
Why?
|
| Reference Values | 1 | 1997 | 319 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 168 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2018 | 187 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1565 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2019 | 262 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 638 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2017 | 274 | 0.030 |
Why?
|
| Chickens | 1 | 2016 | 91 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 570 | 0.030 |
Why?
|
| Rats | 2 | 2017 | 1908 | 0.030 |
Why?
|
| Viruses | 1 | 2016 | 79 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 2014 | 7 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 193 | 0.030 |
Why?
|
| Tretinoin | 1 | 2014 | 49 | 0.030 |
Why?
|
| SOXF Transcription Factors | 1 | 2014 | 10 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 17 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 3 | 1984 | 735 | 0.030 |
Why?
|
| Lipids | 1 | 2016 | 306 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 525 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2014 | 592 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 399 | 0.030 |
Why?
|
| Genes | 2 | 1990 | 94 | 0.030 |
Why?
|
| SOXD Transcription Factors | 1 | 2012 | 5 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 151 | 0.030 |
Why?
|
| Melanophores | 1 | 2012 | 2 | 0.030 |
Why?
|
| Schwann Cells | 1 | 2012 | 7 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2014 | 250 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2014 | 185 | 0.030 |
Why?
|
| Cryptochromes | 1 | 2012 | 42 | 0.030 |
Why?
|
| Oligodendroglia | 1 | 2012 | 33 | 0.030 |
Why?
|
| Support Vector Machine | 1 | 2012 | 23 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 96 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2012 | 35 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2012 | 85 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 646 | 0.020 |
Why?
|
| ras Proteins | 1 | 2012 | 78 | 0.020 |
Why?
|
| Circadian Clocks | 1 | 2012 | 44 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 1991 | 17 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 190 | 0.020 |
Why?
|
| C-Peptide | 1 | 2011 | 23 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1999 | 195 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 230 | 0.020 |
Why?
|
| Chemokines, CXC | 1 | 2011 | 27 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 365 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2011 | 179 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 1145 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 694 | 0.020 |
Why?
|
| Learning | 1 | 2012 | 172 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 309 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1990 | 27 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 300 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 46 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2010 | 81 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 558 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 177 | 0.020 |
Why?
|
| Pregnancy | 1 | 2017 | 2361 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2010 | 131 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2010 | 74 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 381 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 262 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2010 | 87 | 0.020 |
Why?
|
| Motor Activity | 1 | 2012 | 343 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 255 | 0.020 |
Why?
|
| Osteoblasts | 1 | 1990 | 205 | 0.020 |
Why?
|
| Streptococcus | 1 | 1989 | 17 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1991 | 182 | 0.020 |
Why?
|
| Argonaute Proteins | 1 | 2010 | 128 | 0.020 |
Why?
|
| Kinetics | 3 | 1998 | 737 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2009 | 177 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7622 | 0.020 |
Why?
|
| Cyclization | 1 | 1986 | 2 | 0.020 |
Why?
|
| Magnesium Compounds | 1 | 1984 | 2 | 0.010 |
Why?
|
| Nitrogen | 1 | 1984 | 24 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1984 | 66 | 0.010 |
Why?
|
| Adenosine Triphosphate | 2 | 1998 | 288 | 0.010 |
Why?
|
| Isomerases | 3 | 1991 | 4 | 0.010 |
Why?
|
| Temperature | 2 | 1992 | 298 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1992 | 435 | 0.010 |
Why?
|
| beta-Lactams | 3 | 1984 | 11 | 0.010 |
Why?
|
| Methanol | 1 | 1999 | 12 | 0.010 |
Why?
|
| Biotransformation | 1 | 1999 | 19 | 0.010 |
Why?
|
| Culture Media | 1 | 1999 | 77 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1990 | 112 | 0.010 |
Why?
|
| Ketoglutaric Acids | 1 | 1998 | 7 | 0.010 |
Why?
|
| Magnesium Sulfate | 1 | 1998 | 9 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 1998 | 18 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1998 | 15 | 0.010 |
Why?
|
| Ferrous Compounds | 1 | 1998 | 12 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 1998 | 56 | 0.010 |
Why?
|
| Magnesium | 2 | 1992 | 58 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1998 | 51 | 0.010 |
Why?
|
| Interphase | 1 | 1998 | 68 | 0.010 |
Why?
|
| Ethanol | 1 | 1999 | 306 | 0.010 |
Why?
|
| Phosphates | 2 | 1989 | 91 | 0.010 |
Why?
|
| 2-Aminoadipic Acid | 1 | 1992 | 1 | 0.010 |
Why?
|
| Buffers | 1 | 1992 | 20 | 0.010 |
Why?
|
| Valine | 1 | 1992 | 30 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 1992 | 46 | 0.010 |
Why?
|
| Glutathione | 1 | 1992 | 51 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1992 | 89 | 0.010 |
Why?
|
| Oxygenases | 1 | 1991 | 8 | 0.010 |
Why?
|
| Time Factors | 1 | 1999 | 3621 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1991 | 49 | 0.010 |
Why?
|
| Catalysis | 1 | 1992 | 152 | 0.010 |
Why?
|
| Cysteine | 1 | 1992 | 109 | 0.010 |
Why?
|
| Fetus | 1 | 1990 | 97 | 0.010 |
Why?
|
| Iron | 1 | 1989 | 139 | 0.000 |
Why?
|
| Penicillium chrysogenum | 1 | 1988 | 1 | 0.000 |
Why?
|
| Fungal Proteins | 1 | 1988 | 143 | 0.000 |
Why?
|
| Penicillinase | 1 | 1984 | 1 | 0.000 |
Why?
|
| Ammonium Sulfate | 1 | 1984 | 1 | 0.000 |
Why?
|
| Asparagine | 1 | 1984 | 24 | 0.000 |
Why?
|
| Fermentation | 1 | 1984 | 42 | 0.000 |
Why?
|